July 18 (Reuters) - Forward Pharma A/S FWP.O :
* Forward Pharma announces planned distribution of EUR 19.45
per share to shareholders
* Forward Pharma A/S - plans to return EUR 19.45 per share
amounting to a total of EUR 917.7 million to its shareholders
through a capital reduction
* Forward Pharma A/S - plans to complete capital reduction
in early September 2017
* Forward Pharma - decision is based on careful evaluation
of most appropriate capital allocation strategy after receipt of
non-refundable $1.25 billion cash fee from Biogen
* Forward Pharma - capital reduction aligns amount of
working capital with adjusted business activities following
settlement and license agreement with Biogen
* Forward Pharma A/S - shareholders representing over
two-thirds of voting share capital have irrevocably agreed to
vote in favor of capital reduction
Source text for Eikon: ID:nGNXOADSUa
Further company coverage: FWP.O
((Bangalore.newsroom@thomsonreuters.com;))